Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Elan, Transition modify Alzheimer drug trial
Marketwatch
Tuesday, December 15, 2009 - 9:23am
tags:
Alzheimer's disease, Elan, Transition Therapeutics
The Start of a Comeback for Pfizer’s Dividend?
WSJ Online
Tuesday, December 15, 2009 - 9:22am
tags:
Pfizer, dividends
Senators May Omit Health ‘Public Option,’ Medicare Expansion
Bloomberg
Tuesday, December 15, 2009 - 9:13am
tags:
Medicare, healthcare reform, healthcare bill
Pfizer Will Co-Promote Takeda’s Actos Pill in China
Bloomberg
Tuesday, December 15, 2009 - 9:08am
tags:
Takeda, China, Actos, Pfizer
Gilead Drops Blood Pressure Drug
Pharmalot
Tuesday, December 15, 2009 - 8:57am
tags:
Gilead Sciences, hypertension, darusentan
Biotech Calendar: Upcoming FDA Dates
TheStreet.com
Tuesday, December 15, 2009 - 8:54am
tags:
FDA, Dendreon, Arena Pharmaceuticals, Chelsea Therapeutics, Cephalon, Biodel, Auxilium, Novartis, Novo Nordisk, Shire, Vivus, MannKind, Acorda Therapeutics
Teva hails milder restrictions on Parkinson's drug
Yahoo/AP
Monday, December 14, 2009 - 9:13pm
tags:
Teva Pharmaceuticals, Parkinson's Disease, Azilect
Nexavar, Herceptin could gain from cancer meeting
Fierce Pharma
Monday, December 14, 2009 - 6:13pm
tags:
Nexavar, Herceptin, Genentech, breast cancer
GlaxoSmithKline paid close to $15m (£9m) in speaking and consulting fees to US doctors in Q2
FT.com
Monday, December 14, 2009 - 6:05pm
tags:
physician payments, GSK
Abbott Labs to buy Starlims Tech for $123 Mln
Marketwatch
Monday, December 14, 2009 - 6:04pm
tags:
Starlims Tech, M&A, Abbott Laboratories
Pfizer defends Wyeth's conduct on HRT
Fierce Pharma
Monday, December 14, 2009 - 12:02pm
tags:
Wyeth, HRT, Pfizer
FDA says OSI drug effective against lung cancer
Yahoo/AP
Monday, December 14, 2009 - 11:57am
tags:
OSI Pharmaceuticals, lung cancer, FDA, Tarceva
Sunesis Pharmaceutical Gains on Volume Spike
TheStreet.com
Monday, December 14, 2009 - 11:50am
tags:
Sunesis
SIGA's Plummet: Waiting for Conference Call Details
Seeking Alpha
Monday, December 14, 2009 - 11:49am
tags:
SIGA technologies
Cubist Pharmaceuticals pays $92.5M for Calixa
Yahoo/AP
Monday, December 14, 2009 - 11:47am
tags:
Cubist Pharmaceuticals, M&A, Calixa
Source: Sanofi Lays Off Contract Sales Reps
BNET Pharma
Monday, December 14, 2009 - 11:21am
tags:
Sanofi, layoffs, contract sales
FDA approves long-acting Zyprexa
Marketwatch
Monday, December 14, 2009 - 11:20am
tags:
Eli Lilly, Zyprexa, FDA, antipsychotics, schizophrenia
Merck loses effort to dismiss 24 Fosamax cases
Reuters
Monday, December 14, 2009 - 11:18am
tags:
Merck, Fosamax, lawsuits
AstraZeneca Loses A Patent Battle Over Crestor
Pharmalot
Monday, December 14, 2009 - 11:17am
tags:
patents, Crestor, AstraZeneca
Roche-ImmunoGen to Start T-DM1 Trials
TheStreet.com
Monday, December 14, 2009 - 11:16am
tags:
Roche, Immunogen, clinical trials, breast cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.